Concepedia

Ke Zong

KZ

Statistics

Publications

7

Citations

338

H-Index

7

Active since

2019

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Ke Zong is an author at First Affiliated Hospital of Zhengzhou University specializing in oncology, molecular oncology, and microrna in cancer.

Publications per year

2019–2024

7

Publications

7

Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway

Xiaodong Xu, Yan Yu, Ke Zong et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 224 citations · Full text

Life Sciences, Genetics, Oncology +17

miR-30d suppresses proliferation and invasiveness of pancreatic cancer by targeting the SOX4/PI3K-AKT axis and predicts poor outcome

Xiaodong Xu, Ke Zong, Xinxing Wang et al. · Cell Death and Disease · 2021 · 30 citations · Full text

Medicine, Bioinformatics, Oncology +16

Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT

Jianwen Ye, Lei Qi, Jialu Liang et al. · Journal of Cancer · 2021 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

Ferroptosis-related lncRNA NRAV affects the prognosis of hepatocellular carcinoma via the miR-375-3P/SLC7A11 axis

Ke Zong, Cai‐Feng Lin, Kai Luo et al. · BMC Cancer · 2024 · 23 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Jujuboside B alleviates acetaminophen-induced hepatotoxicity in mice by regulating Nrf2-STING signaling pathway

Hongfei Wang, Jia-Shuang Xu, Ke Zong et al. · Ecotoxicology and Environmental Safety · 2023 · 13 citations · Full text

Medicine, Pharmacology, Toxicology +13

1–5 of 7